FDA Approves First Drug to Slow Rare Bone Disease FOP
Adults with a rare disease that turns muscles into bone finally have an FDA-approved treatment that cuts new bone formation by 90%. The drug offers hope to about 900 people worldwide who face progressive loss of mobility from fibrodysplasia ossificans progressiva.
